検索結果 - Vidar Wendel‐Hansen
- 検索結果 1 - 3 結果 / 3
-
1
Subclass-switched anti-spike IgG3 oligoclonal cocktails strongly enhance Fc-mediated opsonization 著者: Arman Izadi, Arsema Hailu, Magdalena Godzwon, Sebastian Wrighton, Berit Olofsson, Tobias Schmidt, Anna Söderlund‐Strand, Elizabeth Elder, Sofia Appelberg, Maria Valsjö, Olivia Larsson, Vidar Wendel‐Hansen, Mats Ohlin, Wael Bahnan, Pontus Nordenfelt
出版事項 2023Artigo -
2
Spike-Dependent Opsonization Indicates Both Dose-Dependent Inhibition of Phagocytosis and That Non-Neutralizing Antibodies Can Confer Protection to SARS-CoV-2 著者: Wael Bahnan, Sebastian Wrighton, Martin Sundwall, Anna Bläckberg, Olivia Larsson, Urban Höglund, Hamed Khakzad, Magdalena Godzwon, Maria Walle, Elisabeth Elder, Anna Söderlund‐Strand, Lotta Happonen, Oscar André, Johannes Kumra Ahnlide, Thomas Hellmark, Vidar Wendel‐Hansen, Robert P. A. Wallin, Johan Malmstöm, Lars Malmström, Mats Ohlin, Magnus Rasmussen, Pontus Nordenfelt
出版事項 2022Artigo -
3
Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial 著者: Richard B. Pollard, Jürgen K. Rockstroh, Giuseppe Pantaleo, David M. Asmuth, Barry Peters, Adriano Lazzarin, Felipe García, Kim Ellefsen, Daniel Podzamczer, Jan van Lunzen, Keikawus Arastéh, Dirk Schürmann, Bonaventura Clotet, William D. Hardy, Ronald T. Mitsuyasu, Graeme Moyle, Andreas Plettenberg, Martin Fisher, Gerd Fätkenheuer, Margaret A. Fischl, Babafemi Taiwo, Ingebjørg Baksaas, Darren Jolliffe, Stefan Persson, Øyvind Jelmert, Arnt-Ove Hovden, Maja A. Sommerfelt, Vidar Wendel‐Hansen, Birger Sørensen
出版事項 2014Artigo
関連主題
Immune system
Immunology
Antibody
Antibody opsonization
Biology
Monoclonal antibody
Opsonin
Phagocytosis
Virology
Adjuvant
Adverse effect
Alternative medicine
Cart
Clinical endpoint
Clinical trial
ELISPOT
Engineering
Human immunodeficiency virus (HIV)
Immunogenicity
Immunoglobulin G
Internal medicine
Mechanical engineering
Medicine
Neutralization
Neutralizing antibody
Pathology
Placebo
Subclass
T cell
Tolerability